Source: Eur Respir J 2002; 20: 1254-1262
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Ewig S., Torres A., Angeles Marcos M., Angrill J., Rano A., de Roux A., Mensa J., Martinez J.A., de la Bellacasa J.P., Bauer T.. Factors associated with unknown aetiology in patients with community-acquired pneumonia. Eur Respir J 2002; 20: 1254-1262

Member's Comments

No comment yet.

Related content which might interest you: Factors associated with unknown aetiology in patients with community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 560s Year: 2002 The main risk factors of the community-acquired pneumonia delayed course Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome Source: Eur Respir J 2007; 30: Suppl. 51, 675s Year: 2007 Impact of age and comorbidity on presentation, aetiology and outcome in patients with community-acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Community-acquired pneumonia in outpatients: aetiology and outcomes}, Source: Eur Respir J 2012; 40: 931-938 Year: 2012 Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2003; 21: 294-302 Year: 2003 Long term survival and risk factors for gram-negative bacillary aetiology in patients with community-acquired pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Community-acquired pneumonia in the elderly Source: Eur Respir Mon; 2009: 43: 111–132 Year: 2009 Community-acquired pneumonia in younger patients is an entity on its own Source: Eur Respir J 2012; 39: 1156-1161 Year: 2012 The peculiarity of etiological agents of community-acquired pneumonia depends on the severity Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006 Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor Source: Eur Respir J 2004; 24 : 779-785 Year: 2004 Community-acquired pneumonia: aetiology and severity scores Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2007; 30: Suppl. 51, 42s Year: 2007 The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome Source: Eur Respir J 2014; 43: 1698-1708 Year: 2014 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression Source: Eur Respir J 2012; 40: 1201-1210 Year: 2012 The tobacco-smoking influence on the community-acquired pneumonia course Source: Eur Respir J 2006; 28: Suppl. 50, 247s Year: 2006